PYROFUZE CORP. – Trademark Portfolio

Entity Type: 03

PYROFUZE CORP. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 7 (Machinery) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MEDWIRE and PYROFUZE. The owner is based in MT. VERNON, NY.

121 SOUTH COLUMBUS AVENUE

MT. VERNON, NY 10553

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEDWIRE
MEDWIRE
Registered 1966
PYROFUZE
PYROFUZE
Registered 1959

Trademark Classifications

PYROFUZE CORP.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

Frequently Asked Questions

How many trademarks does PYROFUZE CORP. have?

PYROFUZE CORP. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does PYROFUZE CORP. file in?

PYROFUZE CORP. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 7 (Machinery). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are PYROFUZE CORP.'s most well-known trademarks?

PYROFUZE CORP.'s registered trademark portfolio includes well-known marks such as MEDWIRE and PYROFUZE. These are among 2 currently registered trademarks in the portfolio.

What is PYROFUZE CORP.'s trademark registration success rate?

PYROFUZE CORP. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.